EN DE
Watch Seers Technology for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Seers Technology (458870) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Seers Technology stock KRW 5,504, price KRW 14,500, that is 62.0% below the price, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare KR

ST Seers Technology logo Some data Nov 6, 2026

Seers Technology

458870 · KQ
Solid, but very expensive

Our calculation puts a fair price 62% below what the stock costs today.

Quality 60/100
Highly profitable · 43.2% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (9/12)
92% return on equity.
Expensive Growth (revenue 3y +247.0 %/yr in KRW)
Wide moat 92/100 · thin data
Some data
Fair value 5,504 KRW · Strongly overvalued (−62.0%)
⚠ Dilution
Watch Seers Technology for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

63,000 KRW 2,860 KRW Fair Value 5,504 KRW Jun 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

29‑month range 2,860 KRW – 63,000 KRW · fair‑value band 3,327 KRW – 6,883 KRW · the 14,500 KRW price screens above the 5,504 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow Seers Technology in your weekly email

Every Wednesday you see whether Seers Technology is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea.

Show moreShow less

It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material.

The company was formerly known as Seers Technology Co., LTD. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.

Stock analysis

Seers Technology (458870) currently trades at 14,500 KRW, while our model-based Fair Value estimate is 5,504 KRW, 62% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 19,640 KRW per share, and 4 of the 23 models we run sit above the 14,500 KRW price.

Bear case: the Asset-Based group reads lowest at 677.98 KRW, and 19 of the 23 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 3,327 KRW (bear) to 6,883 KRW (bull), the price of 14,500 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Seers Technology reported revenue of 48.2B KRW in FY2025 versus 1.4B KRW in FY2021, a compound +142.8%/yr. Reported net income was 16.1B KRW in FY2025.

Key figures

Market cap 553B KRW (≈ $406M) Small · P/E ratio 23.9 · P/S ratio 10.3 · EPS (TTM) 1,100 KRW · Net margin 43.2% · Return on equity 91.8% · Return on assets (EBIT) −22.8% (5-year average) · Operating margin 45.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 92 out of 100 (low confidence).

What moves the price

The share trades about 77% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −15% fair-value upside, at −62%, 458870 screens richer than that median.

Fair Value models

Bear 3,327 KRW Fair Value 5,504 KRW Bull 6,883 KRW
Price 14,500 KRW · Downside -62.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (940.55 KRW per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 540.99 KRW 665.64 KRW 1,046 KRW 75
Growth DCF 525.45 KRW 715.65 KRW 1,018 KRW 74
EPV 3,192 KRW 3,619 KRW 3,981 KRW 71
All 23 models by family
DCF Models
FCF DCF 540.99 KRW 665.64 KRW 1,046 KRW 75
Owner Earnings 2,925 KRW 5,940 KRW 11,779 KRW 67
5Y Revenue Exit 2,406 KRW 4,500 KRW 8,929 KRW 64
5Y EBITDA Exit 3,851 KRW 7,420 KRW 14,449 KRW 66
5Y P/E Exit 5,361 KRW 13,219 KRW 24,198 KRW 62
10Y Revenue Exit 1,725 KRW 4,641 KRW 6,870 KRW 60
10Y EBITDA Exit 2,833 KRW 7,587 KRW 16,393 KRW 58
10Y P/E Exit 3,878 KRW 10,666 KRW 22,417 KRW 54
Earnings-Based
Graham-Dodd 2,875 KRW 20,047 KRW 28,133 KRW 59
Lynch FV 10,357 KRW 14,796 KRW 19,234 KRW 57
PEG = 1.0 10,357 KRW 14,796 KRW 19,234 KRW 53
EPV 3,192 KRW 3,619 KRW 3,981 KRW 71
Multiples
P/E Multiple 6,975 KRW 9,300 KRW 11,625 KRW 63
P/S Multiple 3,322 KRW 4,430 KRW 5,537 KRW 58
P/B Multiple 3,495 KRW 4,660 KRW 5,825 KRW 55
EV/EBIT 5,458 KRW 7,281 KRW 9,104 KRW 66
EV/EBITDA 4,854 KRW 6,476 KRW 8,098 KRW 67
EV/Revenue 2,646 KRW 3,785 KRW 4,925 KRW 53
Asset-Based
NCAV (Graham) 447.47 KRW 677.98 KRW 847.48 KRW 54
Growth DCF
Growth DCF 525.45 KRW 715.65 KRW 1,018 KRW 74
Economic Profit
Residual Income 2,511 KRW 4,103 KRW 10,843 KRW 56
ROIC Compounder 3,914 KRW 5,494 KRW 7,432 KRW 67
Growth Earnings
Growth-Adj P/E 13,748 KRW 19,640 KRW 25,532 KRW 63

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 93
How much profit the company makes from its sales and capital
Quality Growth 100
Are margins and returns getting better?
Cashflow 12
Do the profits arrive as real cash?
Financial strength 93
Debt, balance sheet and risk of trouble
Investment 31
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 12
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+494.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+247.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−316.6% (2021) → 33.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

458870 screens overvalued: fair value 62% below the price. Compare with Abbott Laboratories, →

Compare Seers Technology with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 320 stocks

Beats the industry median on 8/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 60 · Above median
Fair Value upside −62.0% · Below median
Profitability
Return on equity (12 months) 91.8% · Top 25%
Return on assets 29.7% · Top 25%
Net margin (12 months) 43.2% · Top 25%
Operating margin (12 months) 45.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 256.7% · Top 25%

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/E (12 months) 23.9× · Cheaper than median
P/B 13.98× · Priciest 25%
P/S (12 months) 5.70× · Priciest 25%
EV/EBITDA 12.4× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 6
FUTURE (revenue growth)100 · sector 35
PAST (return on equity)100 · sector 17
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 34

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Stryker Corporation SYK $325.87 $358.46 +10% vs 458870
Boston Scientific Corporation BSX $42.75 $47.03 +10% vs 458870
DexCom, Inc DXCM $79.41 $87.35 +10% vs 458870
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥184.15 ¥197.22 +7% vs 458870
GE HealthCare Technologies Inc GEHC $82.38 $69.92 −15% vs 458870
Edwards Lifesciences Corporation EW $102.14 $81.94 −20% vs 458870
Siemens Healthineers AG SHL €44.66 €34.95 −22% vs 458870
Abbott Laboratories, ABT $109.93 $75.28 −32% vs 458870
Medtronic plc MDT $101.80 $65.61 −36% vs 458870
Koninklijke Philips N.V PHIA €27.33 €15.23 −44% vs 458870

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Seers Technology: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Seers Technology Fair Value". https://www.fairvalue-calculator.com/stock/458870

Frequently asked questions

Is Seers Technology (458870) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 5,504 KRW versus a price of 14,500 KRW, about 62% lower (overvalued).
What is the fair value of 458870?
Our model-based fair value for Seers Technology is 5,504 KRW (as of Nov 6, 2026), built from audited fundamentals. The current price: 14,500 KRW.
What is the quality score of 458870?
Seers Technology has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Seers Technology (458870)?
Our model-based price target is the fair value of 5,504 KRW (as of Nov 6, 2026) from 23 valuation models. Cautious scenario 3,327 KRW, optimistic scenario 6,883 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Seers Technology stock forecast for 2026?
Our models put fair value at 5,504 KRW, about 62% lower versus a price of 14,500 KRW (overvalued). Cautious scenario 3,327 KRW, optimistic scenario 6,883 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Seers Technology (458870)?
Seers Technology reported trailing-twelve-month revenue of about 97.1B KRW (latest available figure, as of Nov 6, 2026).
What is the intrinsic value of Seers Technology (458870)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Seers Technology it is 5,504 KRW per share (as of Nov 6, 2026), against a price of 14,500 KRW. It is the blended result of 23 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Seers Technology stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 458870 trades above its calculated fair value: price 14,500 KRW, fair value 5,504 KRW, a gap of about −62% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 458870?
No. The price is what the market pays today (14,500 KRW); the fair value is what the company's own numbers justify (5,504 KRW). For Seers Technology the two are 8,996 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Seers Technology worth?
The market values Seers Technology at about 553B KRW (market capitalisation, as of Nov 6, 2026). Per share that is 14,500 KRW; our models calculate a fair value of 5,504 KRW per share.
What do the bullish and bearish scenarios say about 458870?
Our models span a range for Seers Technology: cautious scenario 3,327 KRW, base 5,504 KRW, optimistic 6,883 KRW per share (as of Nov 6, 2026, price 14,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 458870?
Seers Technology trades at a price-to-earnings ratio of 23.9 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 5,504 KRW is built from several models across several years. Other multiples: P/B 14.0, P/S 5.7, EV/EBITDA 12.4.
How solid is the balance sheet of Seers Technology (458870)?
Balance-sheet figures for Seers Technology (as of Nov 6, 2026): return on equity 91.8%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is 458870 from its 52-week high?
Seers Technology trades at 14,500 KRW, about 77% below its 52-week high of 63,000 KRW and at the low of 14,500 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 5,504 KRW is for.
Which stocks are comparable to Seers Technology?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Seers Technology stock attractive at the current price?
The data as of Nov 6, 2026: price 14,500 KRW, calculated fair value 5,504 KRW (−62%), Quality Score 60/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 458870 calculated?
We run Seers Technology through 23 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 5,504 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Seers Technology itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Seers Technology (458870)?
The closing price on Nov 6, 2026 was 14,500 KRW. Our model-based fair value is 5,504 KRW, about 62% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Seers Technology right now?
The price sits above even our optimistic bull case (6,883 KRW). The favourable scenario is already priced in. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (3,327 KRW to 6,883 KRW) leaves room in how you read the outcome.

Key figures of Seers Technology

How large is the market capitalisation of Seers Technology (458870)?
The market capitalisation of Seers Technology is 553B KRW (≈ $406M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Seers Technology (458870)?
The price-to-sales ratio of Seers Technology is 10.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Seers Technology (458870)?
Earnings per share at Seers Technology are 1,100 KRW (price ÷ EPS = P/E 23.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Seers Technology (458870)?
The net margin of Seers Technology is 43.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Seers Technology (458870)?
The return on equity (ROE) of Seers Technology is 91.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Seers Technology (458870)?
On an EBIT basis the return on assets of Seers Technology is −22.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Seers Technology (458870)?
The operating margin of Seers Technology is 45.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Seers Technology (458870)?
Revenue at Seers Technology is growing +257% versus a year earlier (3y avg +247%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Seers Technology (458870)?
Earnings per share at Seers Technology are growing +730% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Seers Technology (458870) generate?
The free cash flow of Seers Technology is 454M KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Seers Technology (458870) carry?
The net debt of Seers Technology is 438M KRW (fiscal year 2023, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Seers Technology in the live analysis

One click puts Seers Technology on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.